A-061 Performance Evaluation of Improved Versions of Norudia GA Reagents that Reduce Negative Interference During Glycated Albumin Measurements

H Park,B Lee,S Kim
DOI: https://doi.org/10.1093/clinchem/hvad097.059
IF: 12.114
2023-09-27
Clinical Chemistry
Abstract:Abstract Background Glycated albumin (glycoalbumin, GA) is a biomarker that represents the glycemic status of a short period. While the Norudia GA assay kit (Sekisui Medical Co., Ltd., Tokyo, Japan) demonstrated a performance comparative to that of the Lucica GA-L (Asahi Kasei Pharma Corporation, Tokyo, Japan), we have experienced a few cases with extremely low GA levels measured with Norudia GA, inconsistent with the clinical status. Hence, we have evaluated the analytical performance of the improved version of the Norudia GA that claims to have solved the false negative issue. Methods Precision and linearity was evaluated following the guidance of the CLSI EP05-A3 and EP06-A, respectively. Comparative study was performed against the Lucica GA-L and the prior version of Norudia GA with respect to the CLSI EP09-A3. Temperature stability of GA was also assessed. Sample stability under 4 °C and −70 °C was evaluated using 7 specimens including 1 false negative specimen. Along with the initial result, the results after 7, 14, and 28 days of storage were evaluated. To verify the current GA reference interval of our institute, samples from 20 healthy controls (10 males and 10 females) were used according to the CLSI EP28-A3C. Results Precision analysis showed acceptable results. The ranges of repeatability and within-laboratory CV were 1.5%–2.2% and 3.1%–5.3%, respectively. In the linearity analysis, it was demonstrated that the best fit was first order in the polynomial regression with a slope of 1.040 (95% CI, 1.004–1.075) and a coefficient of determination (R2) of 0.998. The method comparison with respect to the Lucica GA-L assay and the original version of the Norudia GA assay exhibited a Pearson’s correlation coefficient (r) of 0.985 and 0.973, respectively. The Bland-Altman plot revealed that the samples with falsely low results obtained using the original Norudia GA resulted in a higher GA result when measured with the improved version of the Norudia GA. Sample stability revealed that there is a tendency of increasing GA upon storage duration in both 4 °C and −70 °C. Transference of the reference interval was verified. Negative interferences were reduced in the improved version of the Norudia GA. Conclusion The new improved version of the Norudia GA assay showed comparable performance in measuring GA as well as reduced interference in samples that had shown false negative results in the original version of the Norudia GA.
medical laboratory technology
What problem does this paper attempt to address?